Ubs Group Ag Renovacor, Inc. Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$1.56 - $4.29 $1,915 - $5,268	1,228 Added 64.9%	3,120 $6,000
Q1 2022 May 16, 2022	BUY	$4.02 - $8.23 $5,475 - $11,209	1,362 Added 256.98%	1,892 $8,000
Q4 2021 Feb 14, 2022	BUY	$6.99 - $9.39 $3,578 - $4,807	512 Added 2844.44%	530 $4,000
Q3 2021 Nov 15, 2021	BUY	$7.73 - $10.65 $139 - $191	18 New	18 $0

Ticker RCOR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,267,700
Description
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). T...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.